On the basis of “ERA-GLONASS” it is planned to create a telemedicine platform “GLONASS Care”. The new digital service will increase fivefold, to 2,500 species, the number of laboratory tests available to residents of all regions of Russia, including hard-to-reach areas of the country.
The development of the platform is provided under an agreement signed today by the management of JSC GLONASS and the medical company Polimed. When creating GLONASS Care, only Russian technological solutions and domestic software will be used.
As part of the agreement, the companies will create a joint venture to implement a comprehensive diagnostic project, thanks to which the Russians will have timely access to online consultations of medical specialists, a wide range of laboratory tests at stationery and mobile points with home visits, as well as ordering medicines. At the same time, users of the GLONASS Care service will be able to submit search results to any clinic in Russia. The legal significance of the information will be ensured by a reliable environment and secure data transmission channels of the state information system “ERA-GLONASS”, in which the results of analyzes can be checked and uploaded to the Unified State Health Information System (EGISZ).
For the convenience of patients, the existing services of Polimed will be used as a mobile laboratory for conducting tests and a remote “decoding” service with recommendations of highly qualified doctors from Moscow based on the results of preliminary diagnosis. The Federal Network of Digital Clinics covers 38 Russian cities, where fixed centers also operate.
In the framework of the project, the ERA monitoring system created on the basis of ERA-GLONASS will be used. It will allow to improve methods, increase the efficiency of mobile laboratories, and ensure control over conditions for transporting vital materials, including compliance with the temperature regime. Igor Milashevsky, Director General of JSC GLONASS, noted that the main state task that ERA-GLONASS effectively performs today is to prevent harm to the life and health of citizens and the environment. “Combining the competencies of GLONASS JSC and Polimed, using the unique technological capabilities of the ERA-GLONASS system for the development of the GLONASS Care service, will increase the availability of medical services, which will ultimately create conditions for improving the quality of life of millions of Russians,” emphasized Igor Milashevsky.
According to experts, about 80% of the Russian population used laboratory diagnostic services in 2021, an increase of 10% from before the novel coronavirus pandemic.
Our company has a wide range of infrastructure for organizing mobile and operational medical diagnostics of health, which is necessary for the implementation of a project to increase the availability of high-quality drugs. Our mission is timely healthcare, helping to avoid extensive treatment in the future and improving quality of life here and now. Together with GLONASS JSC, we will be able to provide such an opportunity to the largest number of residents of our country,” says Alexei Altynbaev, founder of Polimed.